Recorded Chinese product: 二维三七桂利嗪胶囊二维三七桂利嗪胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂
主要成分Active Ingredients
- 其组分为每粒含桂利嗪Qizu Fenwei Meili Hangui Liqin
- 三七总皂苷Sanqi Zongzao Gan
- 维生素EWeisheng Su
- 维生素BWeisheng Su
药物知识说明
其组分为每粒含桂利嗪是一种在国家药监局注册认定的药品。该药品含有三七总皂苷、维生素b、维生素e-29ae96d8等成分。
该药品关联的活性成分包括：三七总皂苷Sanqi Zongzao Gan、维生素b、维生素e。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂。
您可以探索含有相同成分的其他药品：三七总皂苷-c10f5a5e成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 二维三七桂利嗪胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 三七总皂苷Sanqi Zongzao Gan.
Manufacturers recorded for this product: 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂.
Explore other medicines containing the same ingredient: 三七总皂苷 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 二维三七桂利嗪胶囊Recorded Chinese product: 二维三七桂利嗪胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 10粒10 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H44024596
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H44024596
Manufacturer
Chinese legal name: 丽珠集团丽珠制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H44024596
生产企业
丽珠集团丽珠制药厂(国产)
适应症
本品用于缺血性脑血管病及其后遗症。
用法用量
本品口服。一次1粒，一日2次。
不良反应
少数患者用药后有口干、头晕、嗜睡、疲惫、胃部不适感等不良现象，减量或继续用药，症状可自行消失，偶见抑郁和锥体外系反应。
禁忌
1.对本药过敏者禁用。
2.有抑郁症病史者禁用。
3.孕妇及哺乳期妇女禁用。
注意事项
1.高空作业者，驾驶员和有出血倾向患者慎用。
2.疲惫症状逐步加重者应当减量或停药。
3.严格控制药物应用剂量，长期应用出现锥体外系反应时，应当减量或停药。
4.患有帕紧森病等锥体外系疾病时，应慎用。
贮藏
遮光，密封保存。
规格
10粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.